aTyr Pharma Announces Positive Phase 1 Data for ATYR1923 Therapeutic Candidate Pharmaceutical Investing
Naturally Splendid Enterprises Ltd. Sub-Featured in the Cannabis Investor Magazine Cannabis Investing News
Syneos Health and Elligo Announce Strategic Collaboration to Advance Clinical Research for Real-World Patients Biotech Investing
Shire Announces FDA Approval for Label Expansion of CINRYZE® for Prevention of Attacks in Pediatric HAE Biotech Investing
Inovio Announces Treatment of First Patient in Immuno-Oncology Study for Glioblastoma (GBM) with INO-5401 in Combination with Regeneron’s PD-1 Inhibitor Biotech Investing
RISE Life Science Corp. Announces U.S. Retail Debut of Karezza, New CBD Brand Cannabis Investing News
